# Bionano Genomics, Inc.: Form 8-K, filed Feb 10, 2025

- Company: [Bionano Genomics, Inc.](/companies/bngo.md) (CIK 1411690)
- Form: 8-K
- Filed: 2025-02-10
- Accepted by EDGAR: Feb 10, 2025, 17:16 ET
- Period: 2025-02-04
- Accession: 0001140361-25-003762
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1411690/000114036125003762/ef20043253_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1411690/000114036125003762/

## Items reported

- Item 1.02: Termination of a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1411690/000114036125003762/ef20043253_8k.htm

Filed Feb 10, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-003762. Last ingested by Listed: Nov 11, 2026, 00:38 ET. No prices; not investment advice.